Healthtech Startup RapidPulse Scores $48M in Series B Funding

The round also saw previous investors Santé Ventures, Syntheon, Hatteras Venture Partners, and Epidarex Capital, SBI Investment Company Ltd. and Florida Opportunity Fund.

The company will use the funding to complete its ongoing TURBO clinical study and continue expanding its patented technology platform, including a full range of catheter products.

Read More:Deep Tech Startup Pulse Security Bags $8M in Seed Funding

RapidPulse is developing a new aspiration technology designed to improve blood clot removal using a controlled pulsing suction approach. The system is currently being tested in the United States and Europe through the TURBO clinical study to support regulatory approval in the U.S.

Alessandro Piga, CEO of TechWald Next S.p.A., commented, “We evaluated a broad range of emerging stroke technologies and believe RapidPulse represents one of the most compelling innovation opportunities in the field. The company combines differentiated technology, strong intellectual property, and an experienced leadership team. We are excited to support RapidPulse as it advances through this next stage of clinical development.

“RapidPulse is exactly the kind of company S3 Ventures was built to back — a highly differentiated technology, a rigorous clinical strategy, and a team that has earned the confidence of both leading financial investors and a major strategic partner. Stroke remains one of the most acute unmet needs in medicine, and we believe RapidPulse's pulsed aspiration approach has real potential to meaningfully improve outcomes for patients.

“This financing enables us to complete the TURBO study, expand clinical experience across leading stroke centers, and data permitting, seek FDA approval for the RapidPulse system,” said Sean McBrayer Chief Executive Officer of RapidPulse. “We are particularly encouraged by the support of both leading financial investors and one of the largest medical technology companies in the world, Medtronic, reflecting growing recognition of the potential impact of our approach to stroke treatment.”

About RapidPulse

RapidPulse is a medical technology company developing innovative aspiration technology to improve the treatment of acute ischemic stroke. Its proprietary platform is designed to help doctors remove blood clots more effectively and make thrombectomy procedures more consistent and reliable.

Read More:Medtech Startup Xenter Bags $58.25M in Series B Financing